U.S. stocks related to weight loss drugs generally fell on Tuesday, with Novo Nordisk ADR experiencing the largest decline, down 14.64%. Other companies such as ShouTi Bio, GoodRx, and Eli Lilly also saw varying degrees of decline, resulting in poor overall market performanceWallstreetcn·Feb 3, 2026 at 09:09 PMLLY+2.84%NVO+1.43%
GoodRx rose 37%, marking its best single-day performance since September 2020Wallstreetcn·Aug 18, 2025 at 08:01 PMGDRX-0.20%
